Author, year | Country | No. | Location(D2) | Mitosis (/50HPF) | Risk category | Margins resection | Postoperative complication | Imatinib therapy | Median follow-up time | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
≥5 | < 5 | High/Intermediate | Low/Very low | R0 | R1/R2 | |||||||
Gu [28], 2018 | China | T: 62 | T: 32 | T: 10 | T: 52 | T: 28 | T: 34 | T: 61 | T: 1 | T: 11 | T: 12 | > 33 months |
LR: 47 | LR: 18 | LR: 6 | LR: 41 | LR: 20 | LR: 27 | LR: 46 | LR: 1 | LR: 4 | LR: 10 | |||
PD: 15 | PD: 14 | PD: 4 | PD: 11 | PD: 8 | PD: 7 | PD: 15 | PD: 0 | PD: 7 | PD: 2 | |||
Lee, [21] 2018 | South Korea | T: 98 | T: 61 | T: 25 | T: 73 | T: 35 | T: 63 | T: 95 | T: 3 | T: 32 | T: 40 | 46 months |
LR: 53 | LR: NA | LR: 8 | LR: 45 | LR: 11 | LR: 42 | LR: 50 | LR: 3 | LR: 15 | LR: NA | |||
PD: 45 | PD: NA | PD: 17 | PD: 28 | PD: 24 | PD: 21 | PD: 45 | PD: 0 | PD:17 | PD: NA | |||
Zhang, [22] 2018 | China | T: 51 | T: 33 | T: 18 | T: 30 | T: 19 | T: 32 | T: 47 | T: 4 | T: 7 | T: 23 | 36 months |
LR: 37 | LR: 24 | LR: 13 | LR: 21 | LR: 12 | LR: 25 | LR: 33 | LR: 4 | LR: 4 | LR: NA | |||
PD: 14 | PD: 9 | PD: 5 | PD: 9 | PD: 7 | PD: 7 | PD: 14 | PD: 0 | PD: 3 | PD: NA | |||
Shi, [19] 2017 | China | T: 61 | T: 33 | T: 10 | T: 51 | T: 24 | T: 37 | All R0 | T: 24 | T: 13 | > 5 years | |
LR: 45 | LR: 22 | LR: 6 | LR: 39 | LR:15 | LR:30 | LR:15 | LR: NA | |||||
PD: 16 | PD: 11 | PD: 4 | PD: 12 | PD:9 | PD:7 | PD:9 | PD: NA | |||||
Chen, [23] 2017 | China | T: 64 | T: 30 | T: 22 | T: 42 | T: 33 | T: 31 | All R0 | T: 29 | T: 15 | > 5 years | |
LR: 41 | LR: 18 | LR: 12 | LR: 29 | LR: 17 | LR: 24 | LR: 13 | LR: 8 | |||||
PD: 23 | PD: 12 | PD: 10 | PD: 13 | PD: 16 | PD: 7 | PD: 16 | PD: 7 | |||||
Sugase, [20] 2016 | Japan | T: 25 | T: 14 | NA | NA | T: 9 | T: 16 | All R0 | T: 8 | T: 3 | > 5 years | |
LR: 16 | LR: 7 | LR: 3 | LR: 13 | LR: 5 | LR: 1 | |||||||
PD: 9 | PD: 7 | PD: 6 | PD: 3 | PD: 3 | PD: 2 | |||||||
Duffaud, [29] 2014 | France | T: 105 | T: 38 | NA | NA | NA | NA | T: 85 | T: 13 | T: 21 | T: 26 | 36 months |
LR: 82 | LR: NA | LR: 68 | LR: 10 | LR: 15 | LR: NA | |||||||
PD: 23 | PD: NA | PD: 17 | PD: 3 | PD: 6 | PD: NA | |||||||
Zhou, [30] 2013 | China | T: 48 | T: 17 | T: 12 | T: 36 | T: 20 | T: 28 | All R0 | T: 9 | T: 9 | 36 months | |
LR: 34 | LR: 8 | LR: NA | LR: NA | LR: 11 | LR: 23 | LR: 4 | LR: NA | |||||
PD: 14 | PD: 9 | PD: NA | PD: NA | PD: 9 | PD: 5 | PD: 5 | PD: NA | |||||
Colombo, [15] 2012 | Italy, | T: 84 | T: 21 | T: 22 | T: 56 | T: 43 | T: 41 | T: 45 | T: 9 | T: 15 | T: 34 | 42 months |
LR: 56 | LR: 6 | LR: 11 | LR: 41 | LR: 24 | LR: 32 | LR: 26 | LR: 9 | LR: 5 | LR: 19 | |||
PD: 28 | PD: 15 | PD: 11 | PD: 15 | PD: 19 | PD: 9 | PD: 19 | PD: 0 | PD: 10 | PD:15 | |||
Tien, [31] 2010 | China | T: 25 | T: 13 | T: 8 | T: 17 | T: 14 | T: 11 | T: 24 | T: 1 | T: 6 | NOT | 18 months |
LR: 16 | LR: 7 | LR: 4 | LR: 12 | LR: 6 | LR: 10 | LR: 15 | LR: 1 | LR: 2 | ||||
PD: 9 | PD: 6 | PD: 4 | PD: 5 | PD: 8 | PD: 1 | PD: 9 | PD: 0 | PD: 4 |